1. Home
  2. RTX vs GILD Comparison

RTX vs GILD Comparison

Compare RTX & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RTX
  • GILD
  • Stock Information
  • Founded
  • RTX 1934
  • GILD 1987
  • Country
  • RTX United States
  • GILD United States
  • Employees
  • RTX N/A
  • GILD N/A
  • Industry
  • RTX Aerospace
  • GILD Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RTX Industrials
  • GILD Health Care
  • Exchange
  • RTX Nasdaq
  • GILD Nasdaq
  • Market Cap
  • RTX 172.4B
  • GILD 138.7B
  • IPO Year
  • RTX N/A
  • GILD 1992
  • Fundamental
  • Price
  • RTX $146.83
  • GILD $109.64
  • Analyst Decision
  • RTX Buy
  • GILD Buy
  • Analyst Count
  • RTX 14
  • GILD 25
  • Target Price
  • RTX $141.21
  • GILD $110.17
  • AVG Volume (30 Days)
  • RTX 6.1M
  • GILD 8.1M
  • Earning Date
  • RTX 07-22-2025
  • GILD 08-07-2025
  • Dividend Yield
  • RTX 1.85%
  • GILD 2.88%
  • EPS Growth
  • RTX 37.34
  • GILD 1118.07
  • EPS
  • RTX 3.41
  • GILD 4.73
  • Revenue
  • RTX $81,739,000,000.00
  • GILD $28,735,000,000.00
  • Revenue This Year
  • RTX $5.40
  • GILD $1.59
  • Revenue Next Year
  • RTX $5.96
  • GILD $3.67
  • P/E Ratio
  • RTX $43.02
  • GILD $23.18
  • Revenue Growth
  • RTX 15.11
  • GILD 4.68
  • 52 Week Low
  • RTX $100.22
  • GILD $68.14
  • 52 Week High
  • RTX $149.26
  • GILD $119.96
  • Technical
  • Relative Strength Index (RSI)
  • RTX 61.80
  • GILD 49.22
  • Support Level
  • RTX $142.98
  • GILD $110.61
  • Resistance Level
  • RTX $146.78
  • GILD $114.87
  • Average True Range (ATR)
  • RTX 2.16
  • GILD 2.45
  • MACD
  • RTX -0.23
  • GILD 0.11
  • Stochastic Oscillator
  • RTX 96.29
  • GILD 49.76

About RTX RTX Corporation

RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace and to the defense market across three segments: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.

About GILD Gilead Sciences Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Share on Social Networks: